|
1
|
Min JH, Lee HY, Lee KS, Han J, Park K, Ahn
MJ and Lee SJ: Stepwise evolution from a focal pure pulmonary
ground-glass opacity nodule into an invasive lung adenocarcinoma:
an observation for more than 10 years. Lung Cancer. 69:123–126.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pedersen JH, Saghir Z, Wille MM, Thomsen
LH, Skov BG and Ashraf H: Ground-glass opacity lung nodules in the
era of lung cancer ct screening: radiology, pathology, and clinical
management. Oncology (Williston Park). 30:266–274. 2016.PubMed/NCBI
|
|
3
|
Saji H, Matsubayashi J, Akata S, Shimada
Y, Kato Y, Kudo Y, Nagao T, Park J, Kakihana M, Kajiwara N, et al:
Correlation between whole tumor size and solid component size on
high-resolution computed tomography in the prediction of the degree
of pathologic malignancy and the prognostic outcome in primary lung
adenocarcinoma. Acta Radiol. 56:1187–1195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee HY and Lee KS: Ground-glass opacity
nodules: histopathology, imaging evaluation, and clinical
implications. J Thorac Imaging. 26:106–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murakawa T, Konoeda C, Ito T, Inoue Y,
Sano A, Nagayama K and Nakajima J: The ground glass opacity
component can be eliminated from the T-factor assessment of lung
adenocarcinoma. Eur J Cardiothorac Surg. 43:925–932. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu B, Mi RH, Wei XD, Chen L, Ai H, Yuan
FF, Yin QS and Song YP: Clinical analysis of grand glass opacity on
CT as the first change of lung infection accompanied by hematologic
malignancies. Zhonghua Yi Xue Za Zhi. 96:163–166. 2016.(In
Chinese). PubMed/NCBI
|
|
7
|
Nam KB, Kim TJ, Park JS, Chung MJ and Lee
KW: Long-term follow-up results from PET/CT surveillance after
surgical resection of lung adenocarcinoma manifesting as
ground-glass opacity. Medicine (Baltimore). 95:e26342016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee HN, Kim MY, Koo HJ, Kim SS, Yoon DH,
Lee JC and Song JW: and Thin-Section CT: Thin-section ct
characteristics and longitudinal CT follow-up of chemotherapy
induced interstitial pneumonitis: a retrospective cohort study.
Medicine (Baltimore). 95:e24602016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cha MJ, Lee KS, Kim HS, Lee SW, Jeong CJ,
Kim EY and Lee HY: Improvement in imaging diagnosis technique and
modalities for solitary pulmonary nodules: from ground-glass
opacity nodules to part-solid and solid nodules. Expert Rev Respir
Med. 10:261–278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CY, Chen CH, Shen TC, Cheng WC, Hsu
CN, Liao CH, Chen CY, Hsia TC, Liao WC, Tu CY, et al: Lung cancer
screening with low-dose computed tomography: experiences from a
tertiary hospital in Taiwan. J Formos Med Assoc. 115:163–170. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang G and Xie D: Early-stage lung cancer
manifested as ground-glass opacity. Zhonghua Wai Ke Za Zhi.
53:790–793. 2015.(In Chinese). PubMed/NCBI
|
|
12
|
Bak SH, Lee HY, Kim JH, Um SW, Kwon OJ,
Han J, Kim HK, Kim J and Lee KS: Quantitative CT scanning analysis
of pure ground-glass opacity nodules predicts further CT scanning
change. Chest. 149:180–191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ichikawa K, Kobayashi T, Sagawa M,
Katagiri A, Uno Y, Nishioka R and Matsuyama J: A phantom study
investigating the relationship between ground-glass opacity
visibility and physical detectability index in low-dose chest
computed tomography. J Appl Clin Med Phys. 16:50012015.PubMed/NCBI
|
|
14
|
Ikehara M, Saito H, Yamada K, Oshita F,
Noda K, Nakayama H, Masui K, Kameda Y, Komase Y and Miyazawa T:
Prognosis of small adenocarcinoma of the lung based on thin-section
computed tomography and pathological preparations. J Comput Assist
Tomogr. 32:426–431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Honda T, Kondo T, Murakami S, Saito H,
Oshita F, Ito H, Tsuboi M, Nakayama H, Yokose T, Kameda Y, et al:
Radiographic and pathological analysis of small lung adenocarcinoma
using the new IASLC classification. Clin Radiol. 68:e21–e26. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang F, Chen H, Xiang J, Zhang Y, Zhou J,
Hu H, Zhang J and Luo X: Relationship between tumor size and
disease stage in non-small cell lung cancer. BMC Cancer.
10:4742010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patz EF Jr, Rossi S, Harpole DH Jr,
Herndon JE and Goodman PC: Correlation of tumor size and survival
in patients with stage IA non-small cell lung cancer. Chest.
117:1568–1571. 2000. View Article : Google Scholar : PubMed/NCBI
|
